Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

Abstract

Objectives This project was undertaken to assess the risk of malignancy in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors (TNFi) in clinical practice, as recorded in prospective, observational studies.

Keywords

• RANDOMIZED CONTROLLED-TRIALS
• RHEUMATOID-ARTHRITIS
• FACTOR THERAPY
• BIOLOGICS REGISTER
• FACTOR ANTAGONISTS
• ADVERSE EVENTS
• ANTIBODY THERAPY
• CANCER INCIDENCE
• LYMPHOMA RISK
• ETANERCEPT